Tech Company M&A Transactions
Atria Genetics Acquisition
Based in South San Francisco, Atria Genetics was acquired by Celera Group. Celera Group said the transaction price was $33 million.
Transaction Overview
Company Name
Acquired By
Announced On
9/20/2007
Transaction Type
M&A
Amount
$33,000,000
M&A Terms
Celera will acquire substantially all of the assets of Atria for approximately $33 million in cash.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
884 Dubuque Ave.
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Email Address
Not Recorded
Overview
Atria Genetics has a line of human leukocyte antigen (HLA) testing products that are used for identifying potential donors in the matching process for bone marrow transplantation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Pete Krausa
Browse more venture capital transactions:
Prev: 9/20/2007: Care.com venture capital transaction
Next: 9/20/2007: Teneros venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs